Great Lakes Advisors’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-324
Closed -$412K 698
2021
Q2
$412K Sell
324
-7,366
-96% -$8.31M 0.01% 543
2021
Q1
$8.44M Sell
7,690
-14,922
-66% -$19.7M 0.14% 205
2020
Q4
$32.3M Sell
22,612
-665
-3% -$709K 0.58% 42
2020
Q3
$16.4M Buy
23,277
+3,538
+18% +$2.57M 0.35% 91
2020
Q2
$13.8M Buy
+19,739
New +$11.4M 0.34% 93

Other funds holding CDLX

Great Lakes Advisors's CDLX Position: Q3 2021 in Review

Great Lakes Advisors sold out of Cardlytics (CDLX) in Q3 2021, closing a stake of 324 shares — an estimated $412K sold.

Great Lakes Advisors first reported a position in CDLX in Q2 2020 and held it in 5 quarters. The position peaked at $32.3M in Q4 2020. 164 funds tracked by Wall St. Rank hold CDLX as of Q3 2021.

  • Great Lakes Advisors reported no remaining Cardlytics position as of Q3 2021 after selling out during the quarter.
  • Great Lakes Advisors sold 324 Cardlytics shares in Q3 2021, an estimated $412K.
  • Great Lakes Advisors first reported a position in Cardlytics in Q2 2020 and held it in 5 quarters.
  • Great Lakes Advisors's Cardlytics position peaked at $32.3M in Q4 2020.
  • 164 funds tracked by Wall St. Rank held Cardlytics as of Q3 2021.

Based on Great Lakes Advisors's 13F filing for Q3 2021, filed 9 Nov 2021.